Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-26-030261
Filing Date
2026-07-30
Accepted
2026-07-30 16:36:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA 14A ny20077846x3_defa14a.htm DEFA14A 12940
2 logo_ocugen.jpg GRAPHIC 40669
3 ny20077846x3_na01.jpg GRAPHIC 1243080
4 ny20077846x3_na02.jpg GRAPHIC 1295634
  Complete submission text file 0001140361-26-030261.txt   3562062
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36751 | Film No.: 261223953
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)